Glazer Capital LLC’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Glazer Capital LLC’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-75,047	Closed	-$6.97M	–	1002
2021 Q4	$6.97M	Buy	+75,047	New	+$4.94M	0.17%	174

Glazer Capital LLC's ARNA Position: Q1 2022 in Review

Glazer Capital LLC sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 75,047 shares — an estimated $6.97M sold.

Glazer Capital LLC first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $6.97M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Glazer Capital LLC reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Glazer Capital LLC sold 75,047 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $6.97M.
Glazer Capital LLC first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
Glazer Capital LLC's Arena Pharmaceuticals Inc position peaked at $6.97M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Glazer Capital LLC's 13F filing for Q1 2022, filed 17 May 2022.